Sujet : Re: Osoby z tą grupą krwi starzeją się wolniej. Naukowcy potwierdzają De : manta103g (at) *nospam* gmail.com (darius) Groupes :soc.culture.polish Date : 04. Feb 2025, 16:57:23 Autres entêtes Organisation : novaBBS Message-ID :<051d662346fc5e6d7928ef1d14bea4cb@www.novabbs.com> References :1 User-Agent : Rocksolid Light
Prawdziwi naukowcy wiedzą od lat, że grupę krwi można zmienić Modifying a human's blood group is a complex and delicate process that involves genetic and biochemical approaches. Here are some potential ways this could be done: 1. Enzyme Treatment (Biochemical Modification) Scientists have discovered enzymes that can remove specific antigens (A or B) from red blood cells, converting them into type O blood. Example: Bacterial enzymes from Elizabethkingia meningoseptica and Flavobacterium have been shown to strip A and B antigens, effectively converting blood to type O. This method is still experimental and being tested for safety and efficiency. 2. Gene Editing (CRISPR/Cas9) Since blood type is determined by the ABO gene, CRISPR could theoretically be used to alter or silence this gene in stem cells that produce red blood cells. In genetically modified embryos, this could result in a permanent change, but ethical concerns make this highly controversial. 3. Bone Marrow Transplantation Since blood cells are produced in the bone marrow, a person who receives a bone marrow transplant from a donor of a different blood type may develop the donor’s blood type. Example: A patient with type A blood receiving bone marrow from an O-type donor will eventually produce O-type blood. 4. Stem Cell Therapy In the future, induced pluripotent stem cells (iPSCs) could be used to regenerate blood with a modified blood type. Scientists are exploring ways to grow universal donor (O-negative) blood from genetically modified stem cells. Challenges & Ethical Considerations Immune Reactions: The immune system might attack modified blood cells. Ethical Issues: Gene editing in humans raises concerns about unintended consequences. Regulatory Barriers: Such modifications would require extensive testing before clinical use. Would you like details on a specific approach? --